Infantile Spasms Therapeutics Market Report 2018: Global Industry Analysis, Trends, Market Size and Forecasts 2016-2024 - ResearchAndMarkets.com | Financial Buzz

Infantile Spasms Therapeutics Market Report 2018: Global Industry Analysis, Trends, Market Size and Forecasts 2016-2024 – ResearchAndMarkets.com

The “Infantile
Spasms Therapeutics Market: Global Industry Analysis, Trends, Market
Size and Forecasts up to 2024” report has been added to ResearchAndMarkets.com’s
offering.

The report predicts the global infantile spasms therapeutics market to
grow with a CAGR of 2.8% over the forecast period of 2018-2024. The
report on global infantile spasms therapeutics market provides
qualitative and quantitative analysis for the period of 2016 to 2024.

Infantile spasms (IS) is a rare seizure disorder that occurs in young
children, usually under one year of age. Infantile spasm refers to
sudden stiffening of the body, the arms, and the legs or forward bending
of the head. Infantile spasms are caused by an identifiable underlying
condition, such as: Central nervous system infections (such as herpes
simplex virus, meningitis, and encephalitis), abnormal brain development
or injury, Genetic abnormalities and Neurological disorders with skin
lesions.

Growing number of births, rising prevalence of infantile spasms and
product innovations are factors likely to drive the global infantile
spasms therapeutics market. According to the National Organization for
Rare Disorders, the incidence of infantile spasms is 2 to 3 per 10,000
live births, with a lifetime prevalence of 1.5 to 2 per 10,000 children.
However, stringent regulations for product approvals may hinder the
growth of the infantile spasms therapeutics market. Extensive research
and development activities, pipeline drugs, and government initiatives
are a few more factors projected to fuel the global infantile spasms
therapeutics market in the near future.

Geographically, North America is expected to dominate the infantile
spasms (IS) market during the forecast period. U.S held the major market
share in the North America region owing to innovation of new products,
early adoption of treatment procedures and extensive R&D activities.
According to a study carried out in U.S around 2K to 4K new cases of
infantile spasms disorder occur in the U.S. every year. The Asia pacific
region is expected to expand at the highest CAGR during the forecast
period owing to rising awareness about this disease and its treatment
procedures.

Segments Covered

Global Infantile Spasms Therapeutics Market by Dosage

Global Infantile Spasms Therapeutics Market by Route of
Administration

Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/hptsnc/infantile_spasms?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20180622005550/en/